LEXINGTON, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the three months ended June 30, 2021.
News
T2 Biosystems to Report Third Quarter 2021 Financial Results on November 4, 2021
LEXINGTON, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the third quarter of 2021 after market close on Thursday, November 4, 2021. Company management will host a corresponding conference call beginning… Click here to view original post… […]
News
T2 Biosystems Appoints Laura Adams to Its Board of Directors
LEXINGTON, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the appointment of Laura Adams to its Board of Directors, effective immediately. Click here to view original post… […]
News
T2 Biosystems to Participate in the Canaccord Genuity 41st Annual Growth Conference
LEXINGTON, Mass., Aug. 04, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced plans to participate in the upcoming Canaccord Genuity 41st Annual Growth Conference. Click here to view original post… […]
